Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women.
about
Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM studyEpidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patientsThe impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysisSoluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income countryHepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.Screening for chronic kidney disease in HIV-infected patients.HIV-infected persons continue to lose kidney function despite successful antiretroviral therapyProteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection.Microalbuminuria predicts overt proteinuria among patients with HIV infectionProteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individualsRace and other risk factors for incident proteinuria in a national cohort of HIV-infected veterans.Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients.Hepatitis C and the risk of kidney disease and mortality in veterans with HIVExpert opinion on pharmacotherapy of kidney disease in HIV-infected patients.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected womenPre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy.Reduced renal function is associated with progression to AIDS but not with overall mortality in HIV-infected Kenyan adults not initially requiring combination antiretroviral therapy.Relationships between renal parameters and serum and urine markers of inflammation in those with and without HIV infectionMicroalbuminuria in HIV infection.Predictors of impaired renal function among HIV infected patients commencing highly active antiretroviral therapy in Jos, Nigeria.Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic populationEvaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy.Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series.Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.Prevalence and predictors of chronic kidney disease in newly diagnosed human immunodeficiency virus patients in Owerri, Nigeria.Renal dysfunction among HIV-infected patients starting antiretroviral therapy.Renal complications in HIV.Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients.Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population.Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two racesRisk factors for proteinuria in HIV-infected and -uninfected Hispanic drug usersBaseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia.HIV and the kidney.The pharmacologic management of insomnia in patients with HIV.Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women
P2860
Q24635177-53793296-CA4F-492D-9046-5905526F8795Q27009523-E87A2F20-FCBB-4D82-9CC6-0D10FE59C6D0Q27489415-138D7346-A45E-42BF-91DE-E0C0E22F9EF6Q27690715-8EFB4180-1237-40E6-A8C3-87BE7BF6CAC0Q28541930-3ADF29A3-A178-499E-B32E-07E401886283Q33435099-9CF0D242-B25F-4C99-8208-DCA81D20EDE5Q33639802-533BBDBD-98B3-405E-A9F6-691C161E5916Q33731258-D87FAE80-007A-4D36-B293-7CB3EFFA9170Q33806497-DDFC341E-B58B-4C5D-9BC8-F7AE0AC0995DQ33925114-64843D87-B013-4790-A8CF-77D28BCBA0A6Q33941438-4EE24600-63B4-482B-BC18-8F7BE7391F0EQ34048920-CBBE0615-BB05-4D29-B358-321A65F6B913Q34173588-8BCFD939-37DF-425E-8173-30EA5B6724F2Q34375843-8B1201A5-156A-41E8-AAB7-CE7808EFDD3EQ34546552-187865E1-E3A6-4102-B5D0-8C4E97C7C808Q34686870-6CF154AB-3F5A-433C-B608-B89C194D4BD3Q34736194-82AF8EC1-7BF3-490C-A67D-36E84D3F6795Q34828514-1858E266-C575-4C86-A1BC-ED5BC1EE0038Q35059316-95E4E4B5-45CA-47F3-976F-2A8B041F08E1Q35074209-33992A2C-F433-415C-9529-D13BF210258FQ35230397-4D8227CE-59B4-45EA-B1FA-C9677509804DQ35293817-2AD56B1E-15D2-473B-B3A3-8AD5D8FFC62AQ35542976-86B3FBBE-77C6-4E0B-84AC-4E4E8928E95DQ35557335-C4872F23-F93B-4FC2-B2D0-A611B0D4E7FDQ35560802-610B5FC0-6CA1-4B0E-BD25-372EE33BD398Q35604023-0F1C4C35-7FC1-4E29-975E-AF2D08BA4E86Q35891568-F676AB19-D5D3-423C-99FD-DB2BE8125D33Q36024460-6245F395-D443-4D28-9B46-C10E2596790BQ36451062-2962DA92-7592-46FE-8ABD-358C2D9E7B27Q36580386-033B55A5-5CD6-47BB-A749-F679FDD9302CQ36781012-AC6E1634-0BCA-40AA-A666-124ECF99582BQ36823026-D23DBDD9-6979-460C-B312-2F19350656C0Q36852879-2CD1BA47-A011-40F0-808F-C1E73802CC12Q36889886-66D55424-FBD1-4AF9-A53B-35E8CE02D97AQ36908556-77E63C45-E0BB-4DBB-850C-9AF6E01D1B90Q36980292-033CFF68-F0CD-427C-9249-D8B3E52BBECDQ37113579-8028A569-6734-4728-AE48-55FD2853C059Q37141958-2E9FCBB5-B01C-48A9-8139-FBE82C33454FQ37234441-D449DE45-CB63-464E-A283-7B5CB163EA3BQ37574064-C31D42BD-D5C8-49B3-92E8-FD50F7BB12F5
P2860
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Development of proteinuria or ...... rtality in HIV-infected women.
@en
Development of proteinuria or ...... rtality in HIV-infected women.
@nl
type
label
Development of proteinuria or ...... rtality in HIV-infected women.
@en
Development of proteinuria or ...... rtality in HIV-infected women.
@nl
prefLabel
Development of proteinuria or ...... rtality in HIV-infected women.
@en
Development of proteinuria or ...... rtality in HIV-infected women.
@nl
P2093
P1476
Development of proteinuria or ...... rtality in HIV-infected women.
@en
P2093
Anne M Rompalo
Charles C J Carpenter
HIV Epidemiology Research Study Group
John M Williamson
Lynda A Szczech
Paula Schuman
Robert S Klein
Scott D Holmberg
P304
P356
10.1097/00126334-200302010-00013
P407
P577
2003-02-01T00:00:00Z